Budesonide Prophylaxis for Engraftment Syndrome After Hematopoietic Cell Transplantation

Clinical trial NCT05509933 · RECRUITING

Trial details

NCT number: NCT05509933
Sponsor: Henry Ford Health System
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Engraftment Syndrome

Start date: 2022-11-09
Primary completion: 2027-12-30
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.